Cleerly ISCHEMIA vs Eko Murmur Analysis Software (EMAS)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS

AI Verdict

Cleerly ISCHEMIA provides AI-powered analysis of CCTA scans to assess coronary artery ischemia and plaque characteristics, aiding in advanced diagnosis of heart disease. Eko Murmur Analysis Software (EMAS), conversely, uses AI with digital stethoscopes to detect and differentiate heart murmurs, supporting earlier screening and diagnosis of heart and lung conditions. While both are FDA-cleared cardiology AI tools, they operate on distinct data types and address different stages of cardiac assessment, making them complementary rather than direct competitors.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease and ischemia likelihood based on CCTA scans. This tool is ideal for physicians needing to characterize coronary plaque, assess stenosis severity, and estimate fractional flow reserve at a vessel level to guide personalized treatment plans.

View Cleerly ISCHEMIA →

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if you need an AI-powered solution for early detection and differentiation of heart murmurs in both adult and pediatric patients using a digital stethoscope. This tool is best suited for initial screenings, primary care, and telehealth settings where quick, non-invasive clinical decision support for potential heart and lung conditions is paramount.

View Eko Murmur Analysis Software (EMAS) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA Eko Murmur Analysis Software (EMAS)
Pricing Unknown Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales.
Deployment Web-based solution Cloud-based, Mobile App
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers superior usability due to its mobile application and direct integration with digital stethoscopes, enabling a more immediate and portable point-of-care experience. Cleerly ISCHEMIA, while web-based, involves data transfer via a proxy, which may introduce more steps in a clinical workflow.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA provides a more in-depth and quantitative analysis of coronary artery disease, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans. This offers highly granular data crucial for personalized diagnosis and treatment planning for a complex and life-threatening condition. While EMAS offers valuable early detection of murmurs, Cleerly's output directly impacts advanced interventional decision-making.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers a significant advantage by providing a free tier for basic AI analysis, making it highly accessible for initial use and evaluation by a broad range of clinicians. Cleerly ISCHEMIA's pricing requires direct contact, suggesting a potentially higher and less transparent cost structure typically associated with enterprise imaging solutions.

Enterprise Readiness

Cleerly ISCHEMIA

Cleerly ISCHEMIA demonstrates stronger enterprise readiness through its web-based platform, data transfer via Cleerly Proxy (VPN or virtual appliance), and integration with PowerScribe via API. This architecture suggests a design for seamless and robust integration into existing hospital IT and radiology imaging workflows. While EMAS offers EHR-compatible reports, Cleerly's approach is more deeply embedded in enterprise imaging infrastructure.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA exhibits a higher degree of innovation by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans. This capability offers functional and morphological insights that traditionally required more invasive or complex procedures, significantly advancing non-invasive cardiac diagnostics. EMAS, while innovative in its point-of-care application, builds upon existing AI-assisted auscultation concepts.

Support & Docs

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers extensive and clearly documented support resources, including a dedicated Help Center, user manuals, FAQs, and multiple contact channels like email, phone, and chat, with defined service level agreements for enterprise clients. Cleerly's publicly available information does not detail its support and documentation to the same comprehensive extent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA Eko Murmur Analysis Software (EMAS)
Name Cleerly ISCHEMIA Eko Murmur Analysis Software (EMAS)
Company Cleerly Eko Devices
Description Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Radiology Cardiology, Internal Medicine, Pediatrics
Key Features AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API FDA-cleared AI for murmur detection, Analyzes heart sound (PCG) and optional ECG data, Differentiates innocent and structural heart murmurs, Provides clinical decision support, Integrates with Eko digital stethoscopes (CORE 500, DUO, CORE), Mobile app for recording, playback, annotation, and saving, Wireless Bluetooth connectivity to mobile devices, PDF report generation and sharing (EHR compatible)

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Eko Murmur Analysis Software (EMAS).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is designed to analyze CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. Eko EMAS, on the other hand, integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.
Cleerly ISCHEMIA analyzes CCTA scans to provide its insights. Eko EMAS analyzes heart sound (PCG) and optional ECG data collected via Eko digital stethoscopes.
Cleerly ISCHEMIA provides vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment, 3D digital models of coronary arteries, and comprehensive interactive web-based reports. Eko EMAS offers FDA-cleared AI for murmur detection, differentiates innocent and structural heart murmurs, and provides clinical decision support.
Cleerly ISCHEMIA is primarily designed for Cardiology and Radiology specialties. Eko EMAS supports Cardiology, Internal Medicine, and Pediatrics.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.